4-1BB immunotherapy: advances and hurdles.

Authors:
Singh R; Kim YH; Lee SJ; Eom HS; Choi BK.

Journal:
Exp Mol Med

Publication Year: 2024

DOI:
10.1038/s12276-023-01136-4

PMCID:
PMC10834507

PMID:
38172595

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Exp Mol Med

Abbreviation: Exp Mol Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on …
Choi BJ; Park MH; Jin HK and 1 more (2024) - Transparency Score: 3/6
Baf-mediated transcriptional regulation of teashirt is essential for the development of neural prog…
Ko BS; Han MH; Kwon MJ and 13 more (2024) - Transparency Score: 3/6
Cost and time-efficient construction of a 3'-end mRNA library from unpurified bulk RNA in a single …
Choi J; Hyun J; Hyun J and 3 more (2024) - Transparency Score: 3/6
Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies.
Seo DO; Holtzman DM. (2024) - Transparency Score: 3/6
CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cell…
Im JY; Kim SJ; Park JL and 15 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests B.K.C. is employed by Innobationbio. R.S., Y.-H.K., S.-J.L., and H.-S.E. declare no conflicts of interest."

Evidence found in paper:

"Research in our lab is supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (2022R1A2C1005463 to B.K.C.) and National Cancer Center of Korea (NCC) grants funded by the Ministry of Health and Welfare (NCC-2110522 to Y-H.K., NCC- 2110490 to H.S.E.). We would like to thank Hye Young Seo for feedback and critical comments on the manuscript. We acknowledge the use of BioRender.com for creating the graphical illustrations used in this work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025